Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11153 | 937 | 52.2 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PSYCHONEUROPHARMACOL | Address | 7 | 22% | 3% | 29 |
| 2 | NORADRENALINE DOPAMINE INTERACTIONS | Author keyword | 6 | 80% | 0% | 4 |
| 3 | NOREPINEPHRINE DOPAMINE INTERACTIONS | Author keyword | 6 | 100% | 0% | 4 |
| 4 | PSYCHONEUROPHARMACOL PNF | Address | 6 | 100% | 0% | 4 |
| 5 | CHRONIC BINGE COCAINE | Author keyword | 4 | 75% | 0% | 3 |
| 6 | APO SUS | Author keyword | 3 | 100% | 0% | 3 |
| 7 | APO UNSUS | Author keyword | 3 | 100% | 0% | 3 |
| 8 | COGNIT NEUROSCI CNS | Address | 3 | 100% | 0% | 3 |
| 9 | RESERPINE PHARMACOLOGY | Author keyword | 3 | 100% | 0% | 3 |
| 10 | HIGH RESPONDER | Author keyword | 3 | 33% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NORADRENALINE DOPAMINE INTERACTIONS | 6 | 80% | 0% | 4 | Search NORADRENALINE+DOPAMINE+INTERACTIONS | Search NORADRENALINE+DOPAMINE+INTERACTIONS |
| 2 | NOREPINEPHRINE DOPAMINE INTERACTIONS | 6 | 100% | 0% | 4 | Search NOREPINEPHRINE+DOPAMINE+INTERACTIONS | Search NOREPINEPHRINE+DOPAMINE+INTERACTIONS |
| 3 | CHRONIC BINGE COCAINE | 4 | 75% | 0% | 3 | Search CHRONIC+BINGE+COCAINE | Search CHRONIC+BINGE+COCAINE |
| 4 | APO SUS | 3 | 100% | 0% | 3 | Search APO+SUS | Search APO+SUS |
| 5 | APO UNSUS | 3 | 100% | 0% | 3 | Search APO+UNSUS | Search APO+UNSUS |
| 6 | RESERPINE PHARMACOLOGY | 3 | 100% | 0% | 3 | Search RESERPINE+PHARMACOLOGY | Search RESERPINE+PHARMACOLOGY |
| 7 | HIGH RESPONDER | 3 | 33% | 1% | 7 | Search HIGH+RESPONDER | Search HIGH+RESPONDER |
| 8 | COCAINE WITHDRAWAL | 3 | 23% | 1% | 10 | Search COCAINE+WITHDRAWAL | Search COCAINE+WITHDRAWAL |
| 9 | PSYCHOMOTOR EFFECTS | 2 | 36% | 1% | 5 | Search PSYCHOMOTOR+EFFECTS | Search PSYCHOMOTOR+EFFECTS |
| 10 | D PHE CRF | 2 | 67% | 0% | 2 | Search D+PHE+CRF | Search D+PHE+CRF |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LOCOMOTOR RESPONSE | 38 | 47% | 6% | 60 |
| 2 | INDIVIDUAL VULNERABILITY | 31 | 42% | 6% | 57 |
| 3 | INDUCED RELAPSE | 31 | 38% | 7% | 65 |
| 4 | STRESS INDUCED RELAPSE | 13 | 25% | 5% | 43 |
| 5 | ANXIOGENIC DRUG YOHIMBINE | 12 | 44% | 2% | 21 |
| 6 | DOPAMINE RESPONSIVENESS | 11 | 65% | 1% | 11 |
| 7 | LOW RESPONDERS | 11 | 37% | 3% | 24 |
| 8 | HEROIN SEEKING | 11 | 23% | 4% | 40 |
| 9 | ADRENOCORTICOTROPIN ACTH SECRETION | 11 | 78% | 1% | 7 |
| 10 | NOVELTY INDUCED ACTIVITY | 8 | 70% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Neurobiological mechanisms that contribute to stress-related cocaine use | 2014 | 8 | 142 | 41% |
| Stress, dysregulation of drug reward pathways, and the transition to drug dependence | 2007 | 292 | 65 | 20% |
| The role of stress in drug self-administration | 1998 | 377 | 49 | 45% |
| A role for brain stress systems in addiction | 2008 | 302 | 198 | 17% |
| The HPA axis and cocaine reinforcement | 2002 | 139 | 87 | 57% |
| Individual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused Drugs | 2013 | 24 | 472 | 21% |
| Neurobiological mechanisms underlying relapse to cocaine use: contributions of CRF and noradrenergic systems and regulation by glucocorticoids | 2014 | 5 | 185 | 38% |
| Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons | 1996 | 432 | 90 | 44% |
| Stress, alcohol and drug interaction: an update of human research | 2009 | 71 | 213 | 23% |
| Antecedents and consequences of drug abuse in rats selectively bred for high and low response to novelty | 2014 | 8 | 115 | 22% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PSYCHONEUROPHARMACOL | 7 | 22% | 3.1% | 29 |
| 2 | PSYCHONEUROPHARMACOL PNF | 6 | 100% | 0.4% | 4 |
| 3 | COGNIT NEUROSCI CNS | 3 | 100% | 0.3% | 3 |
| 4 | INTER PROGRAM PHYSIOL SCI | 3 | 60% | 0.3% | 3 |
| 5 | NANCY PRITZKER NEUROBIOL | 2 | 67% | 0.2% | 2 |
| 6 | NEUROBIOL ALCOHOL | 2 | 36% | 0.4% | 4 |
| 7 | NIJMEGEN NEUROSCI | 2 | 15% | 1.1% | 10 |
| 8 | INSERM AVENIR TEAM PSYCHOBIOL COMPULS DISORDERS | 1 | 100% | 0.2% | 2 |
| 9 | PRECLIN DEV GRP | 1 | 50% | 0.2% | 2 |
| 10 | UNIDAD INVEST PSICOBIOL DROGODEPENDENCIAS | 1 | 16% | 0.7% | 7 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000231645 | LEWIS//F344//LEW |
| 2 | 0.0000219002 | REINSTATEMENT//SELF ADMINISTRATION//BEHAV NEUROSCI BRANCH |
| 3 | 0.0000189025 | BEHAVIORAL SENSITIZATION//BEHAV PHARMACOL GRP//CONDITIONED DRUG EFFECTS |
| 4 | 0.0000133186 | CONDITIONED PLACE PREFERENCE//PLACE CONDITIONING//INTRACRANIAL SELF ADMINISTRATION |
| 5 | 0.0000129096 | DEV BEHAV NEUROSCI//CANADA CHAIR BEHAV NEUROSCI//PSYCHOL COGNIT NEURAL SCI |
| 6 | 0.0000127858 | SUBPROGRAM BIOPSYCHOL//NIGROSTRIATAL//BIOPSYCHOL BEHAV NEUROSCI PHD SUBPROGRAM |
| 7 | 0.0000110599 | RETROVIROL EPIGENET//POLYANTIGENIC IMMUNOMODULATOR//V HA RAS ONCOGENE |
| 8 | 0.0000104428 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
| 9 | 0.0000082739 | UROCORTIN//CORTICOTROPIN RELEASING FACTOR//UROCORTIN 2 |
| 10 | 0.0000080039 | BED NUCLEUS OF THE STRIA TERMINALIS//EXTENDED AMYGDALA//CORTICAL AUTONOMIC NETWORK |